Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 7/2008

01-07-2008 | Medical Oncology

Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer

Authors: Sabrina Irmscher, MD, Norbert Senninger, MD, Prof., FACS, Christina Schleicher, MD

Published in: Annals of Surgical Oncology | Issue 7/2008

Login to get access

Excerpt

We read with interest the paper by Palmer et al.1 which reports the results of a randomized trial of neoadjuvant chemotherapy in patients with resectable pancreatic cancer. …
Literature
1.
Palmer DH, Stocken DD, Hewitt H, et al. A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: Gemcitabine alone versus gemcitabine combined with cisplatin. Ann Surg Oncol 2007; 14:2088–96PubMedCrossRef
2.
Neoptolemos JP, Stocken DD, Friess H, et al.; European Study Group for Pancreatic Cancer. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350:1200–10PubMedCrossRef
3.
Sasson AR, Hoffman JP, Ross EA, et al. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J Gastrointest Surg 2002; 6:147–57PubMedCrossRef
Metadata
Title
Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer
Authors
Sabrina Irmscher, MD
Norbert Senninger, MD, Prof., FACS
Christina Schleicher, MD
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 7/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-007-9796-7

Other articles of this Issue 7/2008

Annals of Surgical Oncology 7/2008 Go to the issue

Gastrointestinal Oncology

Multivariate Analysis of the Pathologic Features of Esophageal Squamous Cell Cancer: Tumor Budding Is a Significant Independent Prognostic Factor

Hepatic and Pancreatic Tumors

A New Technique of Biliary Reconstruction After “High Hilar Resection” of Hilar Cholangiocarcinoma with Tumor Extension to Secondary and Tertiary Biliary Radicals

Breast Oncology

Management of B3 Lesions and Breast Biopsies

Healthcare Policy and Outcomes

Survival After Resection of Ampullary Carcinoma: A National Population-Based Study

Gastrointestinal Oncology

Perioperative Use of β-blockers and COX-2 Inhibitors May Improve Immune Competence and Reduce the Risk of Tumor Metastasis

Healthcare Policy and Outcomes

Certificate of Need Regulations and the Availability and Use of Cancer Resections